Related Experiment Video
Updated: May 11, 2026
04:00
Corneal Sensitivity Testing Procedure for Ophthalmologic and Optometric Patients
Published on: August 2, 2024
Corneal hysteresis as a risk factor for glaucoma progression: a prospective longitudinal study
Felipe A Medeiros1, Daniel Meira-Freitas, Renato Lisboa
1Hamilton Glaucoma Center and Department of Ophthalmology, University of California, San Diego, California, USA. fmedeiros@glaucoma.ucsd.edu
Ophthalmology
|May 7, 2013
Summary
Corneal hysteresis (CH) is a significant risk factor for glaucoma progression. Lower CH levels correlate with faster visual field loss, highlighting its importance in risk assessment.
Area of Science:
- Ophthalmology
- Glaucoma Research
- Biomechanical Properties of the Cornea
Background:
- Glaucoma is a leading cause of irreversible blindness.
- Assessing glaucoma progression risk is crucial for timely intervention.
- Corneal properties, like corneal hysteresis (CH), are increasingly recognized for their role in ocular health.
Purpose of the Study:
- To investigate corneal hysteresis (CH) as a predictor of visual field progression in glaucoma patients.
- To determine if CH influences the rate of glaucoma disease advancement over time.
Main Methods:
- Prospective observational cohort study involving 114 eyes of 68 glaucoma patients.
- Corneal hysteresis (CH) measured at baseline using Ocular Response Analyzer.
- Visual field progression assessed via visual field index (VFI) using linear mixed models, adjusting for intraocular pressure (IOP) and central corneal thickness (CCT).
Main Results:
- Lower corneal hysteresis (CH) was significantly associated with faster rates of visual field loss (0.25%/year decline per 1 mmHg lower CH).
- The impact of intraocular pressure (IOP) on glaucoma progression was dependent on CH levels.
- CH explained a greater proportion of visual field change variation (17.4%) compared to CCT (5.2%).
Conclusions:
- Corneal hysteresis (CH) is a significant independent risk factor for glaucoma progression.
- Patients with lower CH exhibit a higher risk of accelerated visual field decline.
- CH measurement is a valuable tool for enhancing glaucoma risk stratification and management strategies.
Related Concept Videos
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...